Does Arrowhead Pharmaceuticals (ARWR) stock go up or down depending on the month?
Arrowhead Pharmaceuticals month by month, year by year
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +4.4% | -8.7% | -0.9% | +17.2% | +6.0% | +4.6% | +3.9% | |||||
| 2025 | +5.7% | -4.9% | -32.6% | +9.0% | +15.7% | -1.7% | +0.0% | +39.4% | +56.6% | +22.9% | +24.3% | +26.0% |
| 2024 | +4.9% | +0.0% | -10.9% | -20.9% | +1.5% | +13.2% | +9.9% | -16.6% | -18.7% | -0.7% | +35.4% | -27.8% |
| 2023 | -13.7% | -7.7% | -21.4% | +39.4% | -2.8% | +3.6% | -3.2% | -19.9% | -2.8% | -8.5% | -13.8% | +44.3% |
| 2022 | -20.4% | -16.6% | +4.5% | -10.6% | -18.9% | +5.5% | +20.8% | -6.6% | -16.8% | +5.3% | -7.5% | +26.0% |
| 2021 | +0.6% | +3.2% | -16.8% | +9.7% | -0.2% | +14.1% | -16.3% | -3.1% | -7.0% | +2.2% | +9.8% | -5.4% |
| 2020 | -33.9% | -15.6% | -18.6% | +19.7% | -6.4% | +34.0% | -0.3% | -1.9% | +1.9% | +33.1% | +9.1% | +22.7% |
| 2019 | +13.7% | +38.2% | -6.0% | -2.0% | +31.9% | +11.8% | +9.7% | +17.6% | -17.5% | +42.1% | +82.3% | -13.1% |
| 2018 | +67.9% | +4.9% | +11.3% | -11.0% | +67.0% | +26.9% | +7.1% | +1.3% | +29.9% | -33.6% | +14.2% | -14.5% |
| 2017 | +25.2% | +16.5% | -18.1% | -16.2% | -7.1% | +12.5% | +8.6% | +59.1% | +54.6% | -15.9% | -1.9% | +3.1% |
| 2016 | -43.4% | +12.1% | +23.6% | +20.1% | +5.9% | -13.2% | +12.0% | +16.3% | +6.1% | -21.1% | -75.2% | +7.6% |
| 2015 | -14.5% | +19.3% | -10.2% | +2.1% | -8.7% | +13.5% | -13.6% | -4.0% | -2.9% | -10.6% | +22.7% | -2.7% |
| 2014 | +41.4% | +26.7% | -15.5% | -33.5% | +15.2% | +13.8% | -11.6% | +15.2% | +1.4% | -55.9% | -10.7% | +26.8% |
| 2013 | +11.3% | +0.9% | -5.5% | +6.8% | -9.1% | +88.5% | +10.1% | +37.1% | +23.0% | +17.6% | +31.8% | |
| Average | +2.9% | +5.6% | -7.9% | +1.3% | +7.6% | +9.2% | +8.3% | +8.2% | +9.4% | -1.4% | +8.2% | +9.6% |
| % of years up | 62% | 57% | 29% | 50% | 57% | 79% | 57% | 54% | 54% | 46% | 62% | 62% |
| Years observed | 13 | 14 | 14 | 14 | 14 | 14 | 14 | 13 | 13 | 13 | 13 | 13 |
Arrowhead Pharmaceuticals month by month: the summary
Over 2013-2026, here's what Arrowhead Pharmaceuticals (ARWR) stock did each month, on average: January +2.9% (up 62% of 13 years), February +5.6% (up 57% of 14 years), March -7.9% (up 29% of 14 years), April +1.3% (up 50% of 14 years), May +7.6% (up 57% of 14 years), June +9.2% (up 79% of 14 years), July +8.3% (up 57% of 14 years), August +8.2% (up 54% of 13 years), September +9.4% (up 54% of 13 years), October -1.4% (up 46% of 13 years), November +8.2% (up 62% of 13 years), December +9.6% (up 62% of 13 years). In other words, ARWR historically rose in January, February, April, May, June, July, August, September, November, December, and fell in March, October.
Does Arrowhead Pharmaceuticals really go up in December?
Over 2013-2026, December is Arrowhead Pharmaceuticals's strongest month: +9.6% on average, positive in 8 of 13 years. At the other end, March shows -7.9%. But a monthly gap is often built on one or two extreme years — the table above shows it: look at the spread, not just the average. Seasonality only means something when it has a cause (selling season, earnings calendar, year-end tax effects); with no identified cause, it's probably noise.
Frequently asked questions
Does Arrowhead Pharmaceuticals stock go up or down in June?
Over 14 years, ARWR rose +9.2% on average in June, finishing the month up 11 times out of 14 (79%). Median: +12.1%. It's one of its most consistent months. ⚠️ 14 years of data is not a prediction.
Does Arrowhead Pharmaceuticals stock go up or down in August?
Over 13 years, ARWR rose +8.2% on average in August, finishing the month up 7 times out of 13 (54%). Median: +1.3%. Results are split year to year — there's no clear pattern. ⚠️ 13 years of data is not a prediction.
Does Arrowhead Pharmaceuticals stock go up or down in September?
Over 13 years, ARWR rose +9.4% on average in September, finishing the month up 7 times out of 13 (54%). Median: +1.4%. Results are split year to year — there's no clear pattern. ⚠️ 13 years of data is not a prediction.
Does Arrowhead Pharmaceuticals stock go up or down in July?
Over 14 years, ARWR rose +8.3% on average in July, finishing the month up 8 times out of 14 (57%). Median: +5.5%. Results are split year to year — there's no clear pattern. ⚠️ 14 years of data is not a prediction.
Does Arrowhead Pharmaceuticals stock go up or down in November?
Over 13 years, ARWR rose +8.2% on average in November, finishing the month up 8 times out of 13 (62%). Median: +9.8%. Results are split year to year — there's no clear pattern. ⚠️ 13 years of data is not a prediction.
Does Arrowhead Pharmaceuticals stock go up or down in May?
Over 14 years, ARWR rose +7.6% on average in May, finishing the month up 8 times out of 14 (57%). Median: +3.7%. Results are split year to year — there's no clear pattern. ⚠️ 14 years of data is not a prediction.
What is the best month to buy Arrowhead Pharmaceuticals stock?
Historically, December: over the last 14 years, ARWR gained +9.6% on average that month and finished up 62% of the time (13 years observed). March is the weakest month (-7.9%). This is not a prediction: 14 years is a small sample, and the past is under no obligation to repeat.
Why does Arrowhead Pharmaceuticals stock often rise in December?
December has averaged as its best month over 14 years (+9.6%, up 62% of years). No clearly established recurring seasonal driver explains this month — it's a statistical tendency over 14 years of history, not a prediction.
Is there a best month to invest in the stock market in general?
There's no universal rule: every stock has its own seasonality. For ARWR it's December (+9.6% on average over 14 years) — another stock will look completely different. The calendar effects people cite ("sell in May", the year-end rally) are market-wide averages, not laws: on ARWR, June is the most consistent month (79% positive years). We also rank all 12 months for the whole market.
Does stock seasonality actually work?
Careful. A month that rose 14 times out of 14 can simply be chance: with 12 months and a dozen years, patterns appear naturally even in random data. Seasonality describes what happened; it doesn't explain why and predicts nothing. Treat it as context, never as a standalone buy signal.
What data is this table based on?
On ARWR's real monthly closing prices from 2013 to 2026 (14 years), source Yahoo Finance. Each cell = the price change over that month. Price performance, excluding dividends. Incomplete months and quote gaps are excluded.